Lv31
220 积分 2024-07-09 加入
Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks
6天前
已完结
Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks
13天前
已完结
Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial
20天前
已完结
Advances in the treatment of systemic lupus erythematosus
1个月前
已完结
2025 American College of Rheumatology ( ACR ) Guideline for the Treatment of Systemic Lupus Erythematosus
1个月前
已完结
Characteristics of liquid crystal devices with improved response times
1个月前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
1个月前
已完结
Evaluation and prediction of relapse risk in stable systemic lupus erythematosus patients after glucocorticoid withdrawal (PRESS): an open-label, multicentre, non-inferiority, randomised controlled study in China
1个月前
已完结
皖公网安备34019202002308
